Long-term sickness absence (> 52 weeks of recorded sickness absence or permanent reduced work capacity during follow-up.) | ||||||
Number of body regions with musculoskeletal pain at baseline | Any paina | Bothersome paina | Very bothersome paina | |||
(Pain-intensity cut-off level > 1 (Range 1–7)) | (Pain-intensity cut-off level > 2 (Range 1–7)) | (Pain-intensity cut-off level > 3 (Range 1–7)) | ||||
Model 1 OR (95 % CI)c N = 3745 | ||||||
No pain | Ref. | Ref. | Ref. | |||
1–2 regions | 1.48 (0.62–3.58) | 1.76 (1.04–2.97) | 2.73 (1.82–4.09) | |||
3–5 regions | 4.26 (1.85–9.76) | 5.82 (3.61–9.38) | 7.35 (4.97–10.87) | |||
6–7 regions | 8.00 (3.41–18.77) | 12.26 (6.88–21.88) | 12.22 (6.27–23.83) | |||
Model 2 OR (95 % CI)d N = 3745 | No GP contact (n = 2613) | At least one GP contact (n = 1132) | No GP contact (n = 2613) | At least one GP contact (n = 1132) | No GP contact (n = 2613) | At least one GP contact (n = 1132) |
No pain | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
1–2 regions | 1.32 (0.50–3.52) | 2.13 (0.27–16.88) | 1.53 (0.82–2.84) | 2.36 (0.86–6.48) | 2.57 (1.52–4.34) | 2.57 (1.34–4.92) |
3–5 regions | 3.39 (1.35–8.53) | 6.63 (0.90–48.85) | 4.31 (2.42–7.68) | 8.17 (3.23–20.68) | 6.57 (3.91–11.04) | 6.64 (3.58–12.32) |
6–7 regions | 4.64 (1.73–12.43) | 15.59 (2.10–116.05) | 9.09 (4.35–19.03) | 17.61 (6.21–49.93) | 14.37 (6.46–31.96) | 8.32 (2.45–28.32) |
Model 3 OR (95 % CI)f n = 3002g | ||||||
No pain | Ref. | Ref. | Ref. | |||
1–2 regions | 1.88 (0.56–6.33) | 1.50 (0.80–2.82) | 1.81 (1.10–2.99) | |||
3–5 regions | 3.86 (1.19–12.51) | 3.74 (2.07–6.77) | 4.50 (2.75–7.38) | |||
6–7 regions | 6.84 (2.05–22.80) | 8.42 (4.12–17.21) | 9.42 (4.17–21.27) | |||
Sickness absence of shorter duration (≥ 12 weeks and ≤ 52 weeks of recorded sickness absence during follow-up)e | ||||||
The number of body regions with musculoskeletal pain at baseline | Any paina | Bothersome paina | Very bothersome painb | |||
(Pain-intensity cut-off level > 1 (Range 1–7)) | (Pain-intensity cut-off level > 2 (Range 1–7)) | (Pain-intensity cut-off level > 3 (Range 1–7)) | ||||
Model 1 OR (95 % CI)c n = 3556 | ||||||
No pain | Ref. | Ref. | Ref. | |||
1–2 regions | 0.77 (0.48–1.23) | 1.56 (1.11–2.20) | 1.95 (1.46–2.60) | |||
3–5 regions | 1.17 (0.75–1.83) | 2.56 (1.82–3.61) | 2.60 (1.88–3.61) | |||
6–7 regions | 2.24 (1.38–3.65) | 2.93 (1.66–5.17) | 3.52 (1.68–7.40) | |||
Model 2 OR (95 % CI)d n = 3556 | No GP contact (n = 2512) | At least one GP contact (n = 1044) | No GP contact (n = 2512) | At least one GP contact (n = 1044) | No GP contact (n = 2512) | At least one GP contact (n = 1044) |
No pain | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
1–2 regions | 0.80 (0.43–1.46) | 0.60 (0.28–1.30) | 1.50 (0.97–2.31) | 1.56 (0.88–2.75) | 2.00 (1.38–2.90) | 1.62 (1.02–2.57) |
3–5 regions | 1.35 (0.76–2.39) | 0.68 (0.33–1.42) | 2.17 (1.38–3.42) | 2.48 (1.44–4.27) | 1.99 (1.23–3.21) | 2.57 (1.59–4.15) |
6–7 regions | 2.00 (1.04–3.84) | 1.66 (0.77–3.57) | 2.72 (1.26–5.88) | 2.64 (1.12–6.23) | 3.26 (1.23–8.61) | 3.73 (1.15–12.17) |
Model 3 OR (95 % CI)f n = 2878g | ||||||
No pain | Ref. | Ref. | Ref. | |||
1–2 regions | 0.76 (0.44–1.31) | 1.44 (0.97–2.14) | 1.81 (1.30–2.53) | |||
3–5 regions | 0.98 (0.58–1.65) | 2.14 (1.44–3.20) | 2.04 (1.37–3.02) | |||
6–7 regions | 1.82 (1.03–3.23) | 2.34 (1.23–4.44) | 3.08 (1.33–7.11) |